Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis
Richard J. Allen(University of Leicester), Louise V. Wain(University of Leicester), Wim Timens(University Medical Center Groningen), Tasha E. Fingerlin(University of Colorado Denver), Simon P. Hart(Hull York Medical School), Brian D. Hobbs(Brigham and Women's Hospital), John D. Newell(University of Iowa), Rebecca Braybrooke(National Institute for Health and Care Research), David C. Nickle(Merck & Co., Inc., Rahway, NJ, USA (United States)), Ani Manichaikul(University of Virginia), Ann Millar, Phuwanat Sakornsakolpat(Siriraj Hospital), Rachel K. Putman(Brigham and Women's Hospital), Eunice Oballa(GlaxoSmithKline (United Kingdom)), Helen Parfrey(University of Ulster), Don D. Sin(St. Paul's Hospital), Helen Booth(University College London Hospitals NHS Foundation Trust), Gauri Saini(Nottingham University Hospitals NHS Trust), Xuting R. Sheng, Robin J. McAnulty(University College London), David J. Lederer(Columbia University Irving Medical Center), Nik Hirani(University of Edinburgh), María Molina‐Molina(Universitat de Barcelona), Megan L. Paynton(University of Leicester), George O'connor(Boston University), Richard Hubbard(National Institute for Health and Care Research), Michael Ng(Nuffield Orthopaedic Centre), Hiroto Hatabu(Harvard University), Ayodeji Adegunsoye(University of Chicago), Amy Dressen, Shwu‐Fan Ma(University of Chicago), Mary E. Strek(University of Chicago), Vidya Navaratnam(National Institute for Health and Care Research), Ma’en Obeidat(Nottingham Biomedical Research Centre), Moira K. B. Whyte(University of Edinburgh), Yohan Bossé(Institut universitaire de cardiologie et de pneumologie de Québec), Margaret Neighbors, Naftali Kaminski(Yale University), Beatriz Guillén‐Guío(Universidad de La Laguna), Gunnar Guðmundsson(University of Iceland), Luke M. Kraven(University of Leicester), Philippe Joubert(Institut universitaire de cardiologie et de pneumologie de Québec), Xuan Li(Sun Yat-sen University), Yingze Zhang(University of Pittsburgh), Hanfei Xu(Boston University), Victor E. Ortega(Wake Forest University), Mike Hill(Nuffield Health), Vilmundur Guðnason(University of Wisconsin–Madison), Ke Hao(Icahn School of Medicine at Mount Sinai), William A. Fahy(GlaxoSmithKline (United Kingdom)), Justin M. Oldham(University of Michigan)
American Journal of Respiratory and Critical Care Medicine
November 11, 2019
Cited by 340
Related Papers
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
|Nature Genetics|2006|2.3k
Homologous recombination in DNA repair and DNA damage tolerance
|Cell Research|2008|1.2k
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions
|The Lancet Global Health|2019|1.2k
A variant in CDKAL1 influences insulin response and risk of type 2 diabetes
|Nature Genetics|2007|1.1k